UPMC Enterprises

@UPMCEnterprises

At UPMC Enterprises, we develop and invest in exceptional health care technology. We are seeking to reinvent how consumers engage with the health care industry.

Vrijeme pridruživanja: svibanj 2017.

Tweetovi

Blokirali ste korisnika/cu @UPMCEnterprises

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @UPMCEnterprises

  1. Prikvačeni tweet
    14. sij

    We are proud to announce our commitment of $1 billion to life sciences investments by the year 2024. This announcement marks a major milestone and commitment to supporting ’s mission of life changing medicine. Read how :

    Poništi
  2. Have you been following our "Meet the Executive" series? Get to know Katie Scott, Vice President of MyUPMC and what drives her team to create UPMC's "digital front door"

    Poništi
  3. 3. velj

    In December, the team published their annual 'Top of Mind' survey that captures the top priorities of leaders across the nation. Get the latest:

    Poništi
  4. 31. sij

    Our latest 'Meet the Executive' series features Sara Fest, Senior Director of Marketing and Communications. Visit our blog to meet Sara:

    Poništi
  5. 30. sij

    We are at the Dignity & Respect Champions recognition breakfast where we honor 24 individuals across our system who embody our core values. This year one of our own, Lindsay Crawford, Director of Marketing & Communications, was honored. Congratulations, Lindsay!

    Korisnici , i
    Poništi
  6. 30. sij

    : We rounded up our stories of 2019, visit our blog to read all our latest news:

    Poništi
  7. proslijedio/la je Tweet

    2019 was an exciting year for the ! Now, we are looking forward to what 2020 has in store. We had the chance to sit down with PHDA leadership to learn about what they are looking forward to most.

    Poništi
  8. 29. sij

    Last chance to register for tomorrow's webinar with and and discuss , , , and more. Register here:

    Poništi
  9. 29. sij

    Next up in our 'Meet the Executive' series, we sit down with Wendy Zellner, VP of Get to know Wendy in our blog post:

    Poništi
  10. 29. sij

    Remote patient monitoring to gain big momentum in 2020 via

    Poništi
  11. 28. sij

    - Our partners, , are hosting a , "Improve Patient Care, Optimize ROI, and Adhere to CMS Guidelines: Automating Your Infectious Disease Management Process" When: 1/30/2020 10 am - 11 am EST Register here:

    Poništi
  12. 28. sij

    Don't forget to visit our ! You will get an exclusive look at our executive team, understand how we support our goal of improving healthcare, and meet some furry friends around the office.

    Poništi
  13. proslijedio/la je Tweet

    The findings of 's recent report on the future of include the rise of and , increased access to healthcare, more empowered consumers, and more:

    Poništi
  14. 27. sij

    Health startups netted a record $4B in funding last year via

    Poništi
  15. 27. sij

    Start your week off by catching up on our latest blog post! This week, we explore the "Rights" in . Learn about why genetic sequencing is more than "just a test" and how we can explore the benefits and ultimately improve care.

    Poništi
  16. 24. sij

    Have you read our blog post, "A Look to the Future"? Hear from our team on what trend they are most excited to follow in 2020.

    Poništi
  17. 24. sij

    “Investors had their challenges with cardiovascular disease. But there is an opportunity especially using precision medicine and the concept of understanding real-world data and associated biomarkers.” VP Matthias Kleinz

    Poništi
  18. 24. sij

    .@SamsaraBioCapital's Abraham Bassan: There is almost a philosophical divide between development and approaches. The question is how do we as life sciences investors use that information? We have to get comfortable with the big data black box.

    Poništi
  19. 24. sij

    How can transform the way we treat diseases? Matthias Kleinz: B/c of the complexity of the biology of cardiovascular disease, personalized med may be exactly what it takes to break that down to a more targeted approach.

    Poništi
  20. 24. sij

    "From a VC perspective, the amount of activity in the cardiovascular disease space has been relatively limited. If you look at deals, cardiovascular diseases barely make it into the top 10 in terms of dollars invested." –Matthias Kleinz

    Poništi
  21. 24. sij

    "Cardiovascular disease is a very significant clinical problem. It amounts to about 1 million deaths per year in the United States, despite the fact that we have relatively good treatments." –Matthias Kleinz

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·